Pregled bibliografske jedinice broj: 283113
Serum paraoxonase activities in endemic nephropathy patients on long-term hemodialysis
Serum paraoxonase activities in endemic nephropathy patients on long-term hemodialysis // Collegium Antropologicum, 30:suppl. 1 (2006) (podatak o recenziji nije dostupan, kongresno priopcenje, znanstveni)
CROSBI ID: 283113 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Serum paraoxonase activities in endemic nephropathy patients on long-term hemodialysis
Autori
Tadijanović, Milena ; Rekić, Branka ; Simeon-Rudolf, Vera ; Baričić, Martin ; Juretić, Dubravka ; Miškić, B.
Izvornik
Collegium Antropologicum (0350-6134) 30:suppl. 1
(2006);
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, kongresno priopcenje, znanstveni
Ključne riječi
paraoxonase; long-term hemodialsis; endemic nephropathy
Sažetak
Aim To determine whether paraoxonase activity, paraoxonase phenotype and lipid status are altered in endemic nephropathy patients on long-term hemodialsis treatment as compared to healthy population. Materials and Methods Endemic nephropathy patients (n=31) and control subjects (n=145) were from the area of Slavonski Brod, Croatia. Paraoxon was used as a substrate for measuring basal and sodium chloride-stimulated (NaCl-stimulated) paraoxonase activity, and phenylacetate for measuring arylesterase activity. The double substrate method was used to assign phenotypes. Cholesterol, triglycerides, and high-density lipoprotein cholesterol (HDL-cholesterol) were determined by methods routinely used in medical-biochemical laboratories. Results are expressed as median values and tested by Mann-Whitney rank sum test. The values p<0.05 .were considered significant. Results Basal and NaCl-stimulated paraoxonase activity as well as arylesterase activity were significantly lower in the patient group compared to controls ; 68% (p<0.001), 71% (p<0.001), and 58%(p<0.001), respectively. The distribution of paraoxonase phenotypes in patient group and controls was as follow: AA 45% and 39%, AB 37% and 48%, BB 185 and 13%, respectively. Cholesterol and HDL-cholesterol were significantly decreased (87%, p<0.001 and 71% p<0.001, respectively), whereas triglycerides were significantly increased (195 %, p<0.001) in the patient group compared to control median value. Conclusion Endemic nephropaty patients on long term hemodialysis have decreased paraoxonase /arylesterase activity, which might indicate a greater risk of premature atherogenesis.
Izvorni jezik
Engleski
Znanstvena područja
Farmacija
POVEZANOST RADA
Projekti:
0006634
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb
Profili:
Vera Simeon
(autor)
Dubravka Juretić
(autor)
Hrvoje Miškić
(autor)
Branka Rekić
(autor)
Milena Tadijanović
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Social Science Citation Index (SSCI)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE